Source comparison
Thymosin Alpha-1 Protocol: Dosing Comparison
Maintenance Immune Support 1.6mg 2× weekly (Mon/Thu) 8–12 weeks Sustains Th1/Th2 balance, prevents autoimmune flares Best for long-term autoimmune regulation without cycling off Acute Modulation Phase 3.2mg 4–6 weeks Rapidly upregulates IL-2 and IFN-gamma, red
This comparison does not assign a generated winner or score.
- Maintenance Immune Support
- 1.6mg
- 2× weekly (Mon/Thu)
- 8–12 weeks
- Sustains Th1/Th2 balance, prevents autoimmune flares
- Best for long-term autoimmune regulation without cycling off
- Acute Modulation Phase
- 3.2mg
- 4–6 weeks
- Rapidly upregulates IL-2 and IFN-gamma, reduces inflammatory cytokines
- Used during active flare periods or research phases requiring maximum immune recalibration
- Combination with Thymalin
- 1.6mg Tα1 + 5mg Thymalin
- 2× weekly alternating
- 12 weeks
- Tα1 modulates peripheral T-cells, Thymalin restores thymic epithelial function
- Synergistic approach when thymic involution is suspected alongside autoimmune dysregulation
- Low-Dose Exploratory
- 0.8mg
- 3× weekly (MWF)
- 4 weeks
- Minimal immune stimulation for tolerance assessment
- Conservative starting point for researchers unfamiliar with peptide responses